Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 2 boards, counting each seat separately. Longest: Citius Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Citius Pharmaceuticals Inc. April 6, 202666.8%
-
Citius Pharmaceuticals Inc. March 10, 202571.4%
-
Citius Pharmaceuticals Inc. March 12, 202490.1%
-
Citius Pharmaceuticals Inc. February 7, 202392.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 19, 2025 | Citius Oncology Inc. | Grant or award | +300,000 | — | — |
Questions about Suren G. Dutia
What boards is Suren G. Dutia on?
Suren G. Dutia sits on the boards of Citius Oncology Inc. and Citius Pharmaceuticals Inc.
How long has Suren G. Dutia served on boards?
Our records show at least 5 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.